Myriad Genetics, Inc. (MYGN) financial statements (2021 and earlier)

Company profile

Business Address 320 WAKARA WAY
SALT LAKE CITY, UT 84108
State of Incorp. DE
Fiscal Year End June 30
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments142137181151159145186
Cash and cash equivalents8193111102696465
Short-term investments604470489181122
Receivables122139102111958885
Inventory, net of allowances, customer advances and progress billings28313442382524
Inventory28313442382524
Prepaid expense2525 04 7
Disposal group, including discontinued operation33      
Deferred tax assets    146
Other undisclosed current assets1617913181314
Total current assets:365349326317315284322
Noncurrent Assets
Operating lease, right-of-use asset67
Property, plant and equipment37574351586735
Long-term investments and receivables48553149804184
Long-term investments48553149804184
Intangible assets, net (including goodwill)1,0621,102774808423370374
Goodwill408417319316195177169
Intangible assets, net (excluding goodwill)654685455492228193205
Other noncurrent assets    555
Deferred tax assets, net    (0)3
Other undisclosed noncurrent assets     0(0)
Total noncurrent assets:1,2131,214848907566483501
TOTAL ASSETS:1,5781,5631,1741,224881766824
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8211294887110579
Accounts payable21332622212123
Accrued liabilities61796866504656
Employee-related liabilities     34 
Taxes payable     4 
Deferred revenue4
Debt13      
Disposal group, including discontinued operation11      
Business combination, contingent consideration, liability335127  
Deferred revenue and credits 3221
Contract with customer, liability2
Other undisclosed current liabilities  3  (38) 
Total current liabilities:112118102218726981
Noncurrent Liabilities
Long-term debt and lease obligation2842349    
Long-term debt, excluding current maturities2252349    
Operating lease, liability59
Liabilities, other than long-term debt, including:78671814 
Deferred tax liabilities, net835784 0 
Liability, pension and other postretirement and postemployment benefits    65
Other liabilities 867129 
Business combination, contingent consideration, liability710913  
Other undisclosed liabilities, other than long-term debt (93)(67)(98)   
Other undisclosed noncurrent liabilities9811591222422224
Total noncurrent liabilities:389356107229603524
Total liabilities:501474209447132104105
Stockholders' equity
Stockholders' equity attributable to parent1,0771,089965778748662719
Common stock1111111
Additional paid in capital1,0851,068915851830745718
Accumulated other comprehensive loss(5)(5)(4)(6)(10)(7)(2)
Retained earnings (accumulated deficit)(3)2653(68)(73)(77)2
Stockholders' equity attributable to noncontrolling interest0  (0)   
Total stockholders' equity:1,0771,089965778748662719
TOTAL LIABILITIES AND EQUITY:1,5781,5631,1741,224881766824

Income statement (P&L) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenues813851773771754723778
Revenue, net 771754723778
Cost of revenue(126)(130)(30)(145)(133)(133)(96)
Gross profit:688721743626621590682
Operating expenses(717)(714)(624)(551)(430)(499)(448)
Other undisclosed operating income (loss)   (26)(25)4241
Operating income (loss):(29)811949167134274
Nonoperating income (expense)(9)(8)(2)(7)213
Investment income, nonoperating3321105
Other nonoperating income (expense)(0)1(0)(3)10(2)
Interest and debt expense(12)(12)(3)(1)   
Income (loss) from continuing operations before equity method investments, income taxes:(50)(12)11442169135278
Other undisclosed income (loss) from continuing operations before income taxes(0) 31   
Income (loss) from continuing operations before income taxes:(50)(12)11743169135278
Income tax expense (benefit)12414(21)(44)(55)(102)
Income (loss) before gain (loss) on sale of properties:(38)(8)1312212580176
Other undisclosed net income1212     
Net income (loss):(26)41312212580176
Net income attributable to noncontrolling interest0000   
Net income (loss) available to common stockholders, diluted:(26)51312212580176

Comprehensive Income ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net income (loss):(26)41312212580176
Other comprehensive income (loss)   4(3)(6)(1)
Other undisclosed comprehensive income1      
Comprehensive income (loss):(26)41312612375175
Comprehensive income, net of tax, attributable to noncontrolling interest0000   
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)(1)2    
Comprehensive income (loss), net of tax, attributable to parent:(27)31332612375175

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: